Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,727.00
Ask: 1,728.00
Change: 23.50 (1.38%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,729.50
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BUZZ-U.S. STOCKS ON THE MOVE-Bellicum Pharma, OvaScience, Comstock

Thu, 18th Dec 2014 16:13

(For faster updates on individual market-movers, Eikon usersplease use search string "STXBZ US"; for the Day Aheadnewsletter, http://link.reuters.com/mex49s; for the Morning NewsCall newsletter, http://link.reuters.com/nex49s)U.S. stocks rose on Thursday, with each of the major indexesclimbing more than 1 percent, building on the prior session'srally after the U.S. Federal Reserve's policy statement and oilprices that showed signs of steadying. The Dow Jones industrialaverage rose 0.75 percent, the S&P 500 were up 0.8percent and the Nasdaq Composite were up 1.36 percent.

** BELLICUM PHARMACEUTICALS INC, $26.08, +37.26 pct

The biopharmaceutical company's shares rose as much as 40percent on its debut on Thursday. The company offerd 7.35million shares at $19, above $15-$17 marketed range.

** SILICON IMAGE INC, $4.9501, -26.56 pct

The chipmaker said it expects revenue to fall 10 percent in2015 due to fewer mobile design wins from one its largestcustomers.

** OVASCIENCE INC, $45.93, +31.38 pct

Wedbush Securities raised its rating on the fertilitytreatment developer to "outperform" from "neutral" after companysaid it will launch 2 fertility products and gave update on theprogress of third treatment.

** COMSTOCK RESOURCES INC, $6.02, -12.12 pct

The oil and gas producer said it plans to suspend oildrilling in Eagle Ford shale properties in south and east Texasand Tuscaloosa Marine shale in Mississippi as oil prices plunge.

** TETRAPHASE PHARMACEUTICALS INC, $38.0601, +14.67pct

The drug developer said its antibiotic to treat complicatedintra-abdominal infections was as effective as Merck & Co Inc's ertapenem in a late-stage study.

** DUNKIN' BRANDS GROUP INC, $42.35, -8.37 pct

The Dunkin' Donuts restaurant operator cut its 2015 forecastfor same-store sales growth in the United States and operatingincome growth, citing slowing sales of packaged coffee in itsrestaurants.

** AGENUS INC, $3.664, +9.37 pct

** GLAXOSMITHKLINE PLC, $42.979, +2.23 pct

The biotechnology company said an experimental vaccineagainst shingles by its partner GlaxoSmithKline met itsgoal in a late-stage study. Agenus will get royalties onpotential commercial sales of the vacine.

** ORACLE INC, $44.26, +7.53 pct

The software maker reported a 3.5 percent increase inquarterly revenue on Wednesday, beating Wall Street'sexpectations, as sales at its closely watched cloud servicesbusiness rose 45 percent.

** WINNEBAGO INDUSTRIES INC, $21.695, -9.04 pct

The maker of motorhomes and camping trailers reported alower-than-expected profit as a shortage of workers at a keyplant in rural Iowa and trouble sourcing key components fromsuppliers stymied production of the company's recreationalvehicles.

** REAL GOODS SOLAR INC, $0.6507, +12.19 pct

The solar company said it won more than 80 contracts toinstall rooftop solar power systems on homes and smallbusinesses. The company said the projects represent more than600kW of solar power.

** ACCENTURE PLC, $89.25, +4.63 pct

The consulting and outsourcing company raised its revenueforecast for fiscal 2015 after contract wins helped the companypost better-than-expected first-quarter earnings and revenue. The company said it expects revenue growth of 5-8 percent forthe year ending August on a local currency basis, up from the4-7 percent growth it had estimated earlier.

** RITE AID CORP, $6.77, +11.72 pct

The U.S. drugstore chain raised its full-year earningsforecast after cutting it twice this year as higher sales ofprescription drugs pushed up its profit and revenue in the thirdquarter.

** AK STEEL HOLDING CORP, $5.91, +6.30 pct

The steel maker said it expects fourth-quarter shipments tojump 37 percent compared with the third quarter, helped byacquisitions and strong demand from auto industry.

** THE PANTRY INC, $36.555, +2.91 pct

Canadian convenience store operator Alimentation Couche-TardInc will buy the Kangaroo Express chain operator forabout $861 million to boost its presence in the southeastern andGulf Coast regions. Couche-Tard offered $36.75 per share forPantry, which represents a premium of 3.5 percent to the stock'sWednesday close. Including debt, the deal is valued at $1.7billion. Pantry stock jumped 23 percent on Wednesday after theWall Street Journal reported that the company was nearing a dealto sell itself through an auction.

** BLACKBERRY LTD, $10.14, +1.60 pct

The Canadian mobile technology company launched itslong-awaited Classic on Wednesday, a smartphone it hopes willhelp it win back market share and woo those still using olderversions of its physical keyboard devices.

** ZAGG INC, $6.2, +16.32 pct

The mobile accessories maker raised its full-year net salesforecast to $250 million-$255 million from previous range of$225 million-$235 million. The forecast also beat analysts'average estimate of $232.5 million, according to Thomson ReutersI/B/E/S.

** EXXON MOBIL CORP, $88.57, -0.51 pct

** CHEVRON CORP, $105.89, -0.12 pct

** CONOCOPHILLIPS, $67.09, +0.22 pct

** CHESAPEAKE ENERGY CORP, $18.83, +0.80 pct

Oil company stocks rise after Brent crude jumps 3.3percent to above $63/bbl, extending a rebound from 5-year lowsthis week as more energy firms cut investment in new production.

** HERTZ GLOBAL HOLDINGS INC, $22.64, +6.24 pct

Carl Icahn, the rental car company's largest shareholder,raised stake in the company to 11.34 percent from 10.77 percent.Icahn revealed an 8.48 percent stake in Hertz in August; he hassince ousted CEO Mark Frissora and won three board seats at thecompany.

** KIRBY CORP, $82.325, -7.24 pct

The tank bank operator lowered fourth quarter earningsestimate to $1.10-$1.20 per share from $1.30-$1.40 per share.The company also lowered its full year earnings estimate to$4.84 to $4.94 per share from $5.04-$5.14 per share.

** GENWORTH FINANCIAL INC, $7.89, -0.50 pct

The life and mortgage insurer said the review of long termcare insurance active life margins is taking longer thanexpected. The company said it now expects to complete review onor before fourth quarter results in February.

** JABIL CIRCUIT INC, $20.65, +2.89 pct

The company, which makes phone casings for Apple Inc, forecasts second-quarter revenue above estimates,boosted by strong sales of iPhone 6 and 6 Plus. The companyforecast second quarter core earnings of 39-50 cents per share,higher than analysts' average estimate of profit of 38 cents pershare.

** NATIONAL BANK OF GREECE, $1.94, -2.51 pct

The largest Greek bank's U.S.-listed shares down afterfirst-round presidential vote in Greece saw Prime MinisterAntonis Samaras lose by larger-than-expected margin. (Compiled by Anannya Pramanick in Bangalore; Edited by DonSebastian)

More News
22 Nov 2023 09:48

LONDON BROKER RATINGS: RBC cuts HSBC; Liberum cuts Glencore

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
21 Nov 2023 11:52

GSK to begin phase 3 trials of low-carbon Ventolin inhaler in 2024

(Alliance News) - GSK PLC on Tuesday said it will begin phase 3 trials of a low carbon version of its metered dose inhaler Ventolin using a "next generation" propellant in 2024.

Read more
14 Nov 2023 17:04

LONDON MARKET CLOSE: FTSE 100 underwhelms as stocks jump after US CPI

(Alliance News) - European equities jumped in the wake of a cooler-than-expected US inflation reading, which took some sting out of a recent hawkish reassessment of the Federal Reserve interest rate outlook.

Read more
13 Nov 2023 09:47

GSK hails momelotinib opinion from European Medicines Agency committee

(Alliance News) - GSK PLC on Monday announced that a European Medicines Agency panel has given a positive opinion recommending momelotinib to treat myelofibrosis patients with anaemia.

Read more
9 Nov 2023 15:50

UK dividends calendar - next 7 days

Friday 10 November 
Bodycote PLCdividend payment date
Breedon Group PLCdividend payment date
Chesnara PLCdividend payment date
Finsbury Growth & Income Trust PLCdividend payment date
Invesco Bond Income Plus Ltddividend payment date
JPMorgan Emerging Markets Investment Trust PLCdividend payment date
Kerry Group PLCdividend payment date
Merchants Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCdividend payment date
Mid Wynd International Investment Trust PLCspecial dividend payment date
Montanaro UK Smaller Cos Investment Trust PLCdividend payment date
Senior PLCdividend payment date
Spectris PLCdividend payment date
Spirax-Sarco Engineering PLCdividend payment date
Travis Perkins PLCdividend payment date
Monday 13 November 
no events scheduled 
Tuesday 14 November 
no events scheduled 
Wednesday 15 November 
Coats Group PLCdividend payment date
Ferguson PLCdividend payment date
JP Morgan Mid Cap Investment Trust PLCdividend payment date
Strategic Equity Capital PLCdividend payment date
Thursday 16 November 
abrdn Property Income Trust Ltdex-dividend payment date
Asian Energy Impact Trust PLCex-dividend payment date
Baillie Gifford Japan Trust PLCex-dividend payment date
BlackRock Greater Europe Investment Trust PLCex-dividend payment date
Bunzl PLCex-dividend payment date
Bytes Technology Group PLCex-dividend payment date
Centrica PLCdividend payment date
Coca-Cola Europacific Partners PLCex-dividend payment date
DX Group PLCex-dividend payment date
Empiric Student Property PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
GCP Asset Backed Income Fund Ltdex-dividend payment date
GSK PLCex-dividend payment date
Hargreaves Lansdown PLCex-dividend payment date
Henderson Opportunities Trust PLCex-dividend payment date
ICG Enterprise Trust PLCex-dividend payment date
James Halstead PLCex-dividend payment date
Lancashire Holdings Ltdspecial ex-dividend payment date
Majedie Investments PLCex-dividend payment date
Marks & Spencer Group PLCex-dividend payment date
Murray Income Trust PLCex-dividend payment date
New Star Investment Trust PLCex-dividend payment date
NextEnergy Solar Fund Ltdex-dividend payment date
Octopus Renewables Infrastructure Trust PLCex-dividend payment date
Pershing Square Holdings Ltdex-dividend payment date
Personal Group Holdings PLCdividend payment date
Redrow PLCdividend payment date
Regional REIT Ltdex-dividend payment date
Schroder Oriental Income Fund Ltdex-dividend payment date
Scottish American Investment Co PLCex-dividend payment date
SCS Group PLCex-dividend payment date
Shell PLCex-dividend payment date
Supermarket Income REIT PLCdividend payment date
UK Commercial Property REIT Ltdex-dividend payment date
Unilever PLCex-dividend payment date
Wincanton PLCex-dividend payment date
  
Copyright 2023 Alliance News Ltd. All Rights Reserved.

Read more
8 Nov 2023 09:30

LONDON BROKER RATINGS: UBS downbeat on AJ Bell and Hargreaves Lansdown

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
2 Nov 2023 10:14

LONDON BROKER RATINGS: Bank of America starts Unite Group with 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 Nov 2023 16:52

LONDON MARKET CLOSE: Stocks prosper ahead of central bank rate calls

(Alliance News) - Stocks in London took their lead from a positive start on Wall Street to close higher as investors prepare for interest rate decisions in the UK and US.

Read more
1 Nov 2023 16:35

London close: Stocks rise ahead of US Fed policy decision

(Sharecast News) - London's stock market finished in positive territory on Wednesday, with investors keeping a keen eye on the upcoming policy announcement from the US Federal Reserve.

Read more
1 Nov 2023 08:51

TOP NEWS: GSK ups guidance as boosted by Shingrix and Arexvy

(Alliance News) - GSK PLC on Wednesday hailed the performance of the world's first approved respiratory syncytial virus vaccine Arexvy, as it reported a rise in profit and revenue.

Read more
1 Nov 2023 08:50

LONDON MARKET OPEN: FTSE 100 up, FTSE 250 down as Aston Martin tumbles

(Alliance News) - Stock prices in London opened mixed on Wednesday, ahead of key central bank decisions, as investors were cheered by some strong updates from large-cap listings.

Read more
1 Nov 2023 07:40

LONDON BRIEFING: GSK raises annual guidance following Arexvy launch

(Alliance News) - Stocks in London are called higher on Wednesday, with the main focal point for the day being the upcoming US interest rate decision.

Read more
1 Nov 2023 07:27

GSK hikes guidance after strong third quarter

(Sharecast News) - GSK announced a robust third quarter on Wednesday, prompting an upgrade to its full-year guidance.

Read more
30 Oct 2023 09:01

IN BRIEF: GSK says Jemperli meets endpoint in endometrial cancer trial

GSK PLC - Brentford, west London-based pharmaceutical maker - Jemperli, whose generic name is dostarlimab, meets endpoint of overall survival in phase III Ruby trial on adult patients with primary advanced or recurrent endometrial cancer. Jemperli, combined with standard-of-care chemotherapy, followed by dostarlimab, demonstrated a "statistically significant and clinically meaningful benefit" to the patients in the trial.

Read more
30 Oct 2023 07:06

GSK's Jemperli sees success in endometrial cancer trial

(Sharecast News) - GSK reported encouraging outcomes from part one of the 'RUBY' phase three trial evaluating the efficacy of 'Jemperli', or dostarlimab, with standard chemotherapy for treating adult patients with advanced or recurrent endometrial cancer on Monday.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.